Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
5.27
-0.07 (-1.31%)
At close: Dec 12, 2025, 4:00 PM EST
5.32
+0.05 (0.95%)
After-hours: Dec 12, 2025, 7:59 PM EST
Altimmune Stock Forecast
Stock Price Forecast
The 6 analysts that cover Altimmune stock have a consensus rating of "Strong Buy" and an average price target of $16.33, which forecasts a 209.87% increase in the stock price over the next year. The lowest target is $12 and the highest is $24.
Price Target: $16.33 (+209.87%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 7, 2025.
Analyst Ratings
The average analyst rating for Altimmune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +165.65% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +127.70% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +127.70% | Oct 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +127.70% | Aug 13, 2025 |
| UBS | UBS | Strong Buy Maintains $26 → $24 | Strong Buy | Maintains | $26 → $24 | +355.41% | Aug 13, 2025 |
Financial Forecast
Revenue This Year
5.05K
from 20.00K
Decreased by -74.75%
Revenue Next Year
5.05K
from 5.05K
EPS This Year
-1.00
from -1.34
EPS Next Year
-1.23
from -1.00
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 21,000 | 21,000 | ||||
| Avg | 5,050 | 5,050 | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.0% | 315.8% | ||||
| Avg | -74.8% | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.02 | -1.08 | ||||
| Avg | -1.00 | -1.23 | ||||
| Low | -1.02 | -1.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.